fda approved glp 1 for weight loss approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic Hims Inc. - Novo Nordisk's

Even berberine (the main ingredient in many patches) has poor skin penetration due to its size and structure

452 In vitro experiments showed that curcumin had a protective effect on cell damage caused by excessive copper

Cerebrolysin Research Protocols & Administration Dosing in Published Research Research investigations have employed diverse Cerebrolysin doses depending on species, condition, and route: Preclinical Studies: Rat stroke models: 2.5-7.5 ml/kg optimal range (0.8-7.5 ml/kg studied) Rat TBI models: 2.5 ml/kg identified as optimal dose Mouse neurodegenerative models: 5 ml/kg typical dose Administration timing: Usually 4 hours post-injury, daily for 10-21 days Human Clinical Trials: Acute stroke: 30-50 ml/day intravenously for 10-21 days Vascular dementia: 20-30 ml/day for 4-week cycles Alzheimers disease: 10-60 ml/day for 4-24 weeks Traumatic brain injury: 30-50 ml/day for 10-21 days Important: These dosing regimens are specific to the conditions and species studied and cannot be extrapolated across species or indications due to significant differences in pharmacokinetics, peptide metabolism, receptor expression patterns, and disease pathophysiology

This means they must be prescribed by a registered medical practitioner

Direct stimulation with copper delivery for cross-linking